Sameh Yonan, MD
Pain Medicine · Lorain, OHNPI 1013092147
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,354 of the $2,676 with a category attached, or 88.0%. It is spread thinly across 31 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,156 and has fallen 84.4% since, to $180 in 2025.
Across 92 payments — averaging $29.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$453
- AbbVie$285
- Medtronic$185
- Nevro Corp.$182
- Collegium Pharmaceutical, Inc.$157
- Saluda Medical Americas, Inc.$126
- plus $1K from 25 others
What the payments were for
- Travel & lodging$28611%
- Food & beverage$2,35488%
- Education$361%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 10 | $453 |
| AbbVie(2 entities) | 8 | $285 |
| Medtronic(2 entities) | 4 | $185 |
| Nevro Corp. | 5 | $182 |
| Collegium Pharmaceutical, Inc. | 10 | $157 |
| Saluda Medical Americas, Inc. | 1 | $126 |
| Globus Medical | 1 | $121 |
| Flowonix Medical Incorporated | 1 | $117 |
| Boston Scientific | 1 | $110 |
| MML US, Inc. | 1 | $103 |
| Novartis | 4 | $86 |
| Lilly USA, LLC | 6 | $85 |
| Assertio Therapeutics, Inc. | 5 | $72 |
| Pfizer | 5 | $70 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $66 |
| Amgen | 3 | $59 |
| Tersera Therapeutics LLC | 3 | $55 |
| Stryker | 2 | $51 |
| SPR Therapeutics, Inc | 2 | $41 |
| Almatica Pharma LLC | 3 | $36 |
| Scilex Pharmaceuticals Inc. | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| Averitas Pharma Inc. | 1 | $26 |
| Fidia Pharma USA Inc. | 1 | $24 |
| Nalu Medical, Inc. | 1 | $19 |
| Zyla Life Sciences, Inc. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
| Shionogi Inc | 1 | $12 |
| Bioventus LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Proclaim Family of SCS IPGs$278
- INTELLIS ADAPTIVESTIM$139
- Evoke SCS$126
- ELSA ATP$121
- Prometra II$117
- Omnia$115
- GENERAL PAIN MANAGEMENT$110
- ReActiv8$103
How this compares
$2,676 in reported general payments places this provider in the 55th percentile of 245 pain medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 38 | $4,956 |
| Pregabalin | 48 | $2,024 |
| Gabapentin | 169 | $1,727 |
| Diclofenac Sodium | 68 | $1,636 |
| Baclofen | 45 | $699 |
| Methocarbamol | 86 | $639 |
| Methylprednisolone | 87 | $602 |
| Tizanidine Hcl | 34 | $435 |
| Celecoxib | 12 | $406 |
| Morphine Sulfate ErMorphine Sulfate | 14 | $280 |
| Duloxetine Hcl | 16 | $266 |
| Cyclobenzaprine Hcl | 16 | $156 |
| Tramadol Hcl | 39 | $151 |
| Topiramate | 13 | $57 |
| Ibuprofen | 12 | $57 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Lorain
- Alexander EscobarToledo$638K
- Nagy MekhailCleveland$511K
- Henry VuceticWilloughby$509K
- Tammy DannDayton$431K
- Michael DankoLoveland$381K
- Jonathan SilvermanDayton$234K
- Tristan WeaverColumbus$202K
- Robert BolashCleveland$154K
- Dmitri SouzaCuyahoga Falls$61K
- Aman UpadhyayCleveland$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.